menu
    • menu

    Company profile for Acerus Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acerus is a specialty pharmaceutical company focused on the commercialization and development of innovative products that improve the patient experience. Founded in 2008, Acerus has grown into a fully integrated specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on Men’s Health (Urology and Andrology). Acerus’ foundational product Is NATESTO®, a t...
    Acerus is a specialty pharmaceutical company focused on the commercialization and development of innovative products that improve the patient experience. Founded in 2008, Acerus has grown into a fully integrated specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on Men’s Health (Urology and Andrology). Acerus’ foundational product Is NATESTO®, a testosterone therapy based on our patented nasal gel technology. NATESTO® is approved in the United States, Canada and South Korea for the treatment of adult males diagnosed with hypogonadism.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acerus PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2486 Dunwin Drive Mississauga, Ontario L5L 1J9
    Telephone
    Telephone
    416.679.0771
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aceruspharma.com/English/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acerus-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aceruspharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acerus Update
    Acerus Update

    10 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/11/2702265/0/en/Acerus-Update.html

    GLOBENEWSWIRE
    10 Jul 2023
    Share Share
    Acerus Files For CCAA Protection
    Acerus Files For CCAA Protection

    26 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/26/2596258/0/en/Acerus-Files-For-CCAA-Protection.html

    GLOBENEWSWIRE
    26 Jan 2023
    Share Share
    Acerus Announces Resignation of Director
    Acerus Announces Resignation of Director

    26 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/26/2579502/0/en/Acerus-Announces-Resignation-of-Director.html

    GLOBENEWSWIRE
    26 Dec 2022
    Share Share
    Acerus Announces Amendment to Promissory Note Due to Former Serenity
    Acerus Announces Amendment to Promissory Note Due to Former Serenity

    03 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/03/2526708/0/en/Acerus-Announces-Amendment-to-Promissory-Note-Due-to-Former-Serenity-Shareholders.html

    GLOBENEWSWIRE
    03 Oct 2022
    Share Share
    Cash-depleted Acerus undergoes strategic review
    Cash-depleted Acerus undergoes strategic review

    21 Sep 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/cash-depleted-acerus-undergoes-strategic-review-spark-corporate-magic

    Max Bayer FIERCEBIOTECH
    21 Sep 2022
    Share Share
    Acerus Announces Resignation of CFO Effective November 20, 2022
    Acerus Announces Resignation of CFO Effective November 20, 2022

    23 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/23/2502855/0/en/Acerus-Announces-Resignation-of-CFO-Effective-November-20-2022.html

    GLOBENEWSWIRE
    23 Aug 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search